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1726-4Open, sesame! The gateway to mitigate hepatic injury
using sesaminThe magic phrase “Open, sesame!” from the famous Ara-
bian story, Ali Baba and the Forty Thieves, is familiar and
popular worldwide, and may have originated from the sudden
opening of the sesame capsule to spread seeds. Sesame seeds
and their oil have been utilized as an important foodstuff for
thousands of years. They are regarded as healthy food and
widely used for their distinct taste and flavor.1
Sesamin is the most abundant lignan in sesame oil. It is
well known for its multiple health benefits, including hypo-
cholesterolemic activity, antihypertensive effect, anti-
carcinogenic potential, antiaging effect, immunoregulatory
activity, hypoglycemic action, antithrombotic activity, and
hepatoprotective effect. Among its various biological effects,
the antioxidant activity of sesamin occupies a central role, and
has been well explored in the past few decades.1
Sesamin has been reported to protect against alcohol and
chemical-induced liver injury.1 It is speculated that the
mechanism underlying hepatoprotection of sesamin is via
suppression of the free radical-mediated process triggered by
hepatotoxins.1 In addition to its antioxidant activity, sesamin
has also been demonstrated to work synergistically with
vitamin E against lipid peroxidation.1
Sesamin itself has little antioxidant effect, but it can be
metabolized into several catechol forms in the liver.2 Sesamin
is first metabolized to sesamin monocatechol via cytochrome
P450 2C9 in human liver. Sesamin monocatechol can be fur-
ther metabolized to sesamin dicatechol via cytochrome P450
2C9. These catechol metabolites have been shown to have the
potent ability to scavenge superoxide radicals.2
Many researchers in Taiwan and Japan investigated the role
of sesame oil in the attenuation of hepatic injury. A study byHsu
et al3 revealed that parenteral sesame oil can ameliorate hepatic
oxidative stress after endotoxin intoxication in rats. An addi-
tional investigation by Chang et al4 showed that a mixture of
sesamin and schisandrin B can exert a hepatoprotective effect by
improving the antioxidative capacity in rats under carbon
tetrachloride-induced hepatic oxidative stress. Also, Chan-
drasekaran et al5,6 further demonstrated that sesame oil can
maintain intracellular glutathione levels, reduce reactive oxygen
species levels, and inhibit lipid peroxidation in rats with
acetaminophen-induced acute liver injury. In a study that may
have important implications for drug interaction and drug safety,x.doi.org/10.1016/j.jcma.2014.02.011
901/Copyright  2014 Elsevier Taiwan LLC and the Chinese Medical AssLim et al7 recently disclosed that sesamin can inhibit cyto-
chrome P450 3A4 (CYP3A4) by antagonizing the pregnane X
receptor activation. CYP3A4 is the most abundant cytochrome
P450 and has clinical importance because it metabolizes many
drugs and endogenous substrates. This study suggests a com-
plementary mechanism by which ingestion of this naturally
occurring chemical may decrease the occurrence of adverse
drug reactions secondary to pregnane X receptor-mediated
induction of drug metabolism via CYP3A4.7
Recently, a single-blind, placebo-controlled, parallel-group
and multiple oral dose study was conducted in 48 healthy Jap-
anese to investigate the pharmacokinetics and safety of multiple
oral doses of sesame lignans (sesamin and episesamin).8 No
serious adverse events were observed in this study. Sesamin was
absorbed with a peak plasma concentration at 5 hours. The
plasma concentration of the main metabolite, SC-1, also peaked
at 5 hours. Ultimately, sesamin lignans were confirmed to be
safe and tolerable in this study. The results of the pharmacoki-
netic study demonstrate that no accumulation was observed
following multiple 50 mg doses daily of sesame lignans.8
Although the aforementioned studies cast a spotlight on the
hepatoprotective potential of sesamin, little is known about the
detailed pathway of hepatoprotective effect by sesamin. In this
issue of the Journal of Chinese Medical Association, we are
happy to find that Chiang et al9 have shown that sesamin effec-
tively ameliorated lead and lipopolysaccharide-induced acute
liver injury in rats by the inhibition of proinflammatory cytokines
and nitric oxide. They further pointed out that the inhibition of
liver injury is through the suppression of several signaling path-
ways, such as c-Jun N-terminal kinase, p38 mitogen-activated
protein kinase, cyclooxygenase-2, inducible nitric oxide syn-
thase, and growth arrest DNA damage 45b. It seems that sesamin
can mitigate the hepatic injury through these gateways, which
echoes themagic phrase “Open, sesame!” The result of this study
is crucial in the elucidation of the underlying mechanism of
sesamin in hepatoprotection.9 However, the authors found that
the effect of sesamin was through the suppression of several
signaling pathways. The interaction and real role of these path-
ways in relation to the effect of sesamin are unknown. Further
studies are warranted to reveal the major pathway and the inter-
action of these pathways. Of note, the authors used a lead coupled
with lipopolysaccharide overload model to induce liver injury inociation. All rights reserved.
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previous studies, in which acetaminophen, carbon tetrachloride,
or only lipopolysaccharide was used to induce liver injury.
Whether sesamin has similar hepatoprotective effect in rats
challenged by different hepatotoxins is unknown. Interpretation
of the data and exploration of the results of this study should be
undertaken prudently.
Healthy and safe utilization of cooking oil is always a chal-
lenge worldwide. Sesame seeds and their oil have been used in
human diets for thousands of years globally, especially in Asia.1
There have been an abundance of studies to verify their health
benefits.1,2 Sesamin, as the major lignan of sesame, has a
potentially hepatoprotective effect via its antioxidative property.
Hepatotoxicity is always a major concern in the premarketing
drug development, and postmarketing safety surveillance in
drugs and food. Although many efforts have been enforced to
ameliorate the hepatic injury by health authorities and members
of the pharmacy industries, hepatic injury by drugs, food, and
other chemicals have still occurred unrelentingly.10 Under this
circumstance, a hepatoprotectant is urgently needed. The mech-
anistic exploration of hepatoprotectants, such as the sesamin
study in this issue, iswelcomed in this field. This kindof approach
may help us realize the pathogenesis of liver injury, and con-
solidate our confidence to utilize sesamin and other hep-
atoprotectants properly.Conflicts of interest
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